Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective. In ...

Researchers at the University of Geneva developed CAR T cells targeting the glioblastoma marker PTPRZ1, showing efficacy ...

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor.

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

They have unique cell surface receptors that are generated ... Here authors show that by looking at epigenetic markers in human CD8 + T cells and CAR-T cells, properties and quality of these ...

A team of scientists has discovered a new blood group called MAL, shedding light on a puzzling antigen that has baffled ...

If the FarView radio telescope is built, it would double as a demonstration of two unprecedented activities: mining and ...